Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1

Molecular Cell

Volumn 52, Issue 1, 2013, Pages 37-51

  Zheng, Shunsheng ^a,b   Moehlenbrink, Jutta ^a   Lu, Yi Chien ^a   Zalmas, Lykourgos Panagiotis ^a   Sagum, CariA ^c   Carr, Simon ^a   McGouran, Joanna F ^d   Alexander, Leila ^e   Fedorov, Oleg ^e   Munro, Shonagh ^a   Kessler, Benedikt ^d   Bedford, Mark T ^c   Yu, Qiang ^b   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIN A; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN P100; PROTEIN P100 TSN; PROTEIN PRMT5; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; METHYLATION; NONHUMAN; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; APOPTOSIS; ARGININE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYCLIN A; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; METHYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-ARGININE N-METHYLTRANSFERASES; REPRESSOR PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84885378025     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.08.039     Document Type: Article

References (22)

1. Adams P.D., Sellers W.R., Sharma S.K., Wu A.D., Nalin C.M., Kaelin W.G. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 1996, 16:6623-6633.
2. Blanco M.A., Alečković M., Hua Y., Li T., Wei Y., Xu Z., Cristea I.M., Kang Y. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J.Biol. Chem. 2011, 286:19982-19992.
3. Chen Y.N., Sharma S.K., Ramsey T.M., Jiang L., Martin M.S., Baker K., Adams P.D., Bair K.W., Kaelin W.G. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc. Natl. Acad. Sci. USA 1999, 96:4325-4329.
4. Chen C., Nott T.J., Jin J., Pawson T. Deciphering arginine methylation: Tudor tells the tale. Nat. Rev. Mol. Cell Biol. 2011, 12:629-642.
5. Cho E.C., Zheng S., Munro S., Liu G., Carr S.M., Moehlenbrink J., Lu Y.C., Stimson L., Khan O., Konietzny R., et al. Arginine methylation controls growth regulation by E2F-1. EMBO J. 2012, 31:1785-1797.
6. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin W.G., Livingston D.M., Orkin S.H., Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996, 85:549-561.
7. Frolov M.V., Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J.Cell Sci. 2004, 117:2173-2181.
8. Iaquinta P.J., Lees J.A. Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol. 2007, 19:649-657.
9. Jansson M., Durant S.T., Cho E.C., Sheahan S., Edelmann M., Kessler B., La Thangue N.B. Arginine methylation regulates the p53 response. Nat. Cell Biol. 2008, 10:1431-1439.
10. Karkhanis V., Hu Y.J., Baiocchi R.A., Imbalzano A.N., Sif S. Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem. Sci. 2011, 36:633-641.
11. Kim J., Daniel J., Espejo A., Lake A., Krishna M., Xia L., Zhang Y., Bedford M.T. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 2006, 7:397-403.
12. La Thangue N.B. The yin and yang of E2F-1: balancing life and death. Nat. Cell Biol. 2003, 5:587-589.
13. Liu K., Chen C., Guo Y., Lam R., Bian C., Xu C., Zhao D.Y., Jin J., MacKenzie F., Pawson T., Min J. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain. Proc. Natl. Acad. Sci. USA 2010, 107:18398-18403.
14. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
15. Polager S., Ginsberg D. E2F - at the crossroads of life and death. Trends Cell Biol. 2008, 18:528-535.
16. Shaw N., Zhao M., Cheng C., Xu H., Saarikettu J., Li Y., Da Y., Yao Z., Silvennoinen O., Yang J., et al. The multifunctional human p100 protein 'hooks' methylated ligands. Nat. Struct. Mol. Biol. 2007, 14:779-784.
17. Stevens C., La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 2003, 412:157-169.
18. Stevens C., La Thangue N.B. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst.) 2004, 3:1071-1079.
19. Stevens C., Smith L., La Thangue N.B. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 2003, 5:401-409.
20. Välineva T., Yang J., Palovuori R., Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J.Biol. Chem. 2005, 280:14989-14996.
21. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996, 85:537-548.
22. Yang Y., Lu Y., Espejo A., Wu J., Xu W., Liang S., Bedford M.T. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol. Cell 2010, 40:1016-1023.